endothelin-1 has been researched along with Brain-Diseases* in 2 studies
2 review(s) available for endothelin-1 and Brain-Diseases
Article | Year |
---|---|
Endothelin ET
In brain disorders, reactive astrocytes, which are characterized by hypertrophy of the cell body and proliferative properties, are commonly observed. As reactive astrocytes are involved in the pathogenesis of several brain disorders, the control of astrocytic function has been proposed as a therapeutic strategy, and target molecules to effectively control astrocytic functions have been investigated. The production of brain endothelin-1 (ET-1), which increases in brain disorders, is involved in the pathophysiological response of the nervous system. Endothelin B (ET Topics: Alzheimer Disease; Animals; Astrocytes; Brain Diseases; Brain Injuries; Brain Ischemia; Endothelin-1; Humans; Neuralgia; Receptor, Endothelin B | 2021 |
Pathogenesis of pancreatic encephalopathy in severe acute pancreatitis.
Pancreatic encephalopathy (PE) is a serious complication of severe acute pancreatitis (SAP). In recent years, more and more PE cases have been reported worldwide, and the onset PE in the early stage was regarded as a poor prognosis sign of SAP, but the pathogenesis of PE in SAP still has not been clarified in the past decade. The purpose of this review is to elucidate the possible pathogenesis of PE in SAP.. The English-language literature concerning PE in this review came from the Database of MEDLINE (period of 1991-2005), and the keywords of severe acute pancreatitis and pancreatic encephalopathy were used in the searching.. Many factors were involved in the pathogenesis of PE in SAP. Pancreatin activation, excessive release of cytokines and oxygen free radicals, microcirculation abnormalities of hemodynamic disturbance, ET-1/NO ratio, hypoxemia, bacterial infection, water and electrolyte imbalance, and vitamin B1 deficiency participated in the development of PE in SAP.. The pathogenesis of PE in SAP has not yet been fully understood. The development of PE in SAP may be a multi-factor process. To find out the possible inducing factor is essential to the clinical management of PE in SAP. Topics: Acute Disease; Animals; Brain Diseases; Cytokines; Endothelin-1; Humans; Hypoxia; Nitric Oxide; Pancreatin; Pancreatitis; Thiamine Deficiency | 2007 |